Stroke (szélütés): ki dolgozik rajta

Intézményenként egy kártya. Válassz célpontot, és csak az azon dolgozó csoportok maradnak.

• Minden célpont
• NLRP3 0
• NRF2 0
• GLP-1 4
• PCSK9 12
• AKT 0
• PI3K 0
• SGLT2 2
• BDNF 2
• TLR4 0
• AMPK 0
• STAT3 0
• mTOR 0
• VEGF 0
• ERK 0
• HIF-1 0
• SIRT1 0
• PPAR 1
• STING 0
• GPX4 0
• MMP-9 0
• HMGB1 0
• IL-6 0
• APOE 0
• JAK 0
• NOTCH3 1
• MAPK 0
• NMDA 0
• TNF 0
• TP53 0
• DPP-4 1
• CTNNB1 0
• CXCR4 0
• IL-1 1
• TREM2 0
• FTO 0
• IL-17 0
• JNK 0
• COX-2 0
• PTEN 0
• PARP 0
• YAP 0
• AQP4 0
• CCR5 1
• BCL-2 0
• EGFR 0
• PINK1 0
• HSP90 0
• AR 0
• GIP 0
• HDAC 0
• PD-L1 0
• PDE4 0
• PDGFR 0
• TFEB 0
• ATM 0
• B7-H3 0
• CGRP 0
• FOXP3 0
• MAPT 0
• MEK 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-DN-JD

  Understanding learning variability to personalise training and boost knowledge-driven, efficient and acceptable neurotechnologies (VARIABILITI)

  Universite de Bordeaux· Bordeaux, Franciaország· EU contribution 4 606 137 EUR· until 2032. febr.· 11 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC

  Supermassive Black Hole Transients: From Single Brush Strokes to the Entire Painting (BHFlares)

  Tel Aviv University· Tel Aviv, Izrael· EU contribution 2 053 750 EUR· until 2031. dec.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Human–robot Adaptive Role MOdulation with Neuro-inspired trajectorY (HARMONY)

  Scuola Universitaria Professionale Della Svizzera Italiana· Manno, Svájc· EU contribution 292 119 EUR· until 2028. dec.· 2 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  From lab to life: measuring and modulating musculoskeletal load in human locomotion (MSKLOAD)

  Norges Idrettshogskole· Oslo, Norvégia· EU contribution 334 273 EUR· until 2029. jún.· 2 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Emerging risk factors for stroke: Deciphering the biological mechanisms underlying the impact of chronic stress on the microbiome and microglia epigenetics. (MicroStress)

  Ludwig-Maximilians-Universitaet Muenchen· Planegg, Németország· EU contribution 202 125 EUR· until 2028. dec.

5 of 115 running projects, newest first. Listed amounts together: 396,1 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

Ebben a nézetben egy vizsgálat sem jelzi, hogy megosztaná a résztvevői adatokat.

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 38
• Organoids 7
• Mendelian Randomization Analysis 168
• CRISPR-Cas Systems 4
• Gene Expression Profiling 74
• Sequence Analysis, RNA 12
• Exome Sequencing 8
• Proteomics 98
• Metabolomics 71
• Mass Spectrometry 12
• Flow Cytometry 12
• Immunohistochemistry 33
• Xenograft Model Antitumor Assays 1
• Positron-Emission Tomography 33
• Magnetic Resonance Imaging 852
• Machine Learning 354
• Deep Learning 123
• Cohort Studies 943
• Genome-Wide Association Study 140

• DTI-ALPS as a Biomarker of Small Vessel Disease Progression and Amyloid-β in Normal Aging: A 3-Year Longitudinal Study.

  Hum Brain Mapp, 2026. okt.

• Vascular Hybrid Imaging: PET/Computed Tomography and PET/Magnetic Resonance of Neurovascular Disease.

  Neuroimaging Clin N Am, 2026. szept.

• Predicting Functional Prognosis in Supratentorial Stroke Using [¹⁸F]Fluoro-2-deoxy-D-glucose Positron Emission Tomography.

  Yonsei Med J, 2026. szept.

• [History and Clinical Significance of Perfusion Imaging in Acute Ischemic Stroke:From the Penumbra Concept to Tissue-Based Patient Selection].

  No Shinkei Geka, 2026. szept.

• A novel mWGA-TYR PET reporter gene system for in vivo visualization of whole brain-level neural circuit.

  Eur J Nucl Med Mol Imaging, 2026. júl.

• Personalized metabolic connectome analysis reveals glucose heterogeneity in ischemic cerebrovascular disease.

  Eur J Nucl Med Mol Imaging, 2026. júl.

• Blood‒brain barrier permeability assessment: from biomimetic models to multimodal imaging.

  J Zhejiang Univ Sci B, 2026. júl.

• PET molecular imaging of in vivo brain metabolism, synaptic density and glial reactivity changes after neural stem cell transplantation on a rat model of ischemic stroke.

  Eur J Nucl Med Mol Imaging, 2026. júl.

• Organ-Specific Perfusion Response to Adenosine as Measured Using Total-Body PET.

  J Nucl Med, 2026. júl.

• Positron emission tomography for diagnosing cerebrovascular disorders: a scoping review.

  Neurol Sci, 2026. jún.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.